(Q36720328)

15 August 2017

1 reference

title

Established treatments for acute ischaemic stroke (English)

1 reference

15 August 2017

Aslam M Khaja

1

1 reference

15 August 2017

James C Grotta

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

369

1 reference

15 August 2017

issue

9558

1 reference

15 August 2017

page(s)

319-330

1 reference

Tissue plasminogen activator for acute ischemic stroke

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

European Stroke Initiative Recommendations for Stroke Management – Update 2003

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Validation of admission criteria to a stroke unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Accuracy of bedside diagnosis in stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Neurogenic cardiac effects of cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Electrocardiographic changes and myocardial damage in patients with acute cerebrovascular accidents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The effect of acute stroke on cardiac functions as observed in an intensive stroke care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke after acute myocardial infarction: relation to infarct size

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Cardiac arrhythmias in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Atrial fibrillation after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Is admission chest radiography of any clinical value in acute stroke patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Interrater reliability of the NIH stroke scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Comparison of Neurological Scales and Scoring Systems for Acute Stroke Prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Misdiagnosis of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Autopsy correlations of computerized tomography: Experience with 6,000 CT scans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Unenhanced CT and acute stroke physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute stroke: usefulness of early CT findings before thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Fast magnetic resonance diffusion-weighted imaging of acute human stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Identification of major ischemic change. Diffusion-weighted imaging versus computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Normal diffusion-weighted MRI during stroke-like deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Diffusion-weighted magnetic resonance imaging in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Does the mismatch match the penumbra? Magnetic resonance imaging and positron emission tomography in early ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Multimodal MR examination in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

MR angiography compared to conventional selective angiography in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Comparison of MRI and CT for detection of acute intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Practical limitations of acute stroke MRI due to patient-related problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Survival and outcome after endotracheal intubation for acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Elective intubation for neurologic deterioration after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Treatment of stroke on an intensive stroke unit: a novel concept

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Fever in acute stroke worsens prognosis. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Combating hyperthermia in acute stroke: a significant clinical concern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Influence of admission body temperature on stroke mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

ST segment depression detected by continuous electrocardiography in patients with acute ischemic stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Neurogenic ST depression in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Myocardial damage from acute cerebral lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Cardiac sequelae of acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Prognostic significance of hyperglycemia in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Pharmacological elevation of blood pressure in acute stroke. Clinical effects and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Hemodynamics of stroke patients under therapy with low molecular weight hydroxyethyl starch

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

A blind controlled trial of dextran 40 in the treatment of ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. The Hemodilution in Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Adjusted hypervolemic hemodilution in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analyses. Scandinavian Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute hypertension after stroke: the scientific basis for treatment decisions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Pathophysiology and management of hypertension in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Lack of clinical significance of early ischemic changes on computed tomography in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Hypertension and its treatment in the NINDS rt-PA Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Number Needed to Treat Estimates Incorporating Effects Over the Entire Range of Clinical Outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Time Is Brain--Quantified

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intra-arterial thrombolysis for acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

1 reference

7 January 2021

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Acute intravenous--intra-arterial revascularization therapy for severe ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Emergent use of anticoagulation for treatment of patients with ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Antithrombotic and thrombolytic therapy for ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The rapid anticoagulation prevents ischemic damage study in acute stroke--final results from the writing committee

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Use of intravenous heparin by North American neurologists: do the data matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Extracranial arterial dissection: anticoagulation is the treatment of choice: for.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Carotid Artery Dissection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Heparin treatment in sinus venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Counci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

EFNS guideline on the treatment of cerebral venous and sinus thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke unit treatment improves long-term quality of life: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke unit treatment. 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke Units in Their Natural Habitat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Who benefits from treatment and rehabilitation in a stroke Unit? A community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Treatment and rehabilitation on a stroke unit improves 5-year survival. A community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Recommendations for the establishment of primary stroke centers. Brain Attack Coalition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Measures to improve recovery in the acute phase of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Antithrombotic therapy for venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The evolution of swallowing neuroanatomy and physiology in humans: a practical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Treatment of dysphagia improves nutritional conditions in stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Lingual discoordination and dysphagia following acute stroke: analyses of lesion localization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Assessing the laryngeal cough reflex and the risk of developing pneumonia after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Assessing the laryngeal cough reflex and the risk of developing pneumonia after stroke: an interhospital comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Validation of the 3-oz water swallow test for aspiration following stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

High incidence of pneumonia in elderly patients with basal ganglia infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Incontinence after stroke in a rehabilitation setting: outcome associations and predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Stroke treatment and prevention: from clinical trials to daily practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Different predictors of neurological worsening in different causes of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Ancrod for the treatment of acute ischemic brain infarction. The Ancrod Stroke Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Seizures after stroke: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Complications of acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Early seizures after acute stroke. Risk of late seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Epileptic seizures in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The Saudi Stroke Data Bank. Analysis of the first 1000 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Status epilepticus in stroke: report on a hospital-based stroke cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Treatment or prevention of complications of acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Brain edema after stroke. Clinical syndrome and intracranial pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Evaluation of Hyperventilation in Treatment of Head Injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The value of intracranial pressure monitoring in acute hemispheric stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Dexamethasone as Treatment in Cerebrovascular Disease. 2. A Controlled Study in Acute Cerebral Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Steroid Therapy in Acute Cerebral Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

High dose steroid treatment in cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

The effects of mannitol on cerebral edema after large hemispheric cerebral infarct

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Mannitol dose requirements in brain-injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Treatment of right hemispheric cerebral infarction by hemicraniectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

An aggressive approach to massive middle cerebral artery infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Functional recovery after decompressive craniectomy for cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Outcome of acute supratentorial cerebral infarction in patients under 60. Development of a prognostic grading system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Decompressive surgery in space-occupying hemispheric infarction: results of an open, prospective trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

One-year outcome after decompressive surgery for massive nondominant hemispheric infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Early hemicraniectomy in patients with complete middle cerebral artery infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Outcome after external decompression for massive cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

Is decompressive craniectomy for acute cerebral infarction of any benefit?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960154-8

7 January 2021

10.1016/S0140-6736(07)60154-8

Identifiers

DOI

1 reference

15 August 2017

1 reference